BioSpectrum Asia Magazine - March 2020Add to Favorites

BioSpectrum Asia Magazine - March 2020Add to Favorites

Go Unlimited with Magzter GOLD

Read BioSpectrum Asia along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99 $49.99

$4/month

Save 50% Hurry, Offer Ends in 5 Days
(OR)

Subscribe only to BioSpectrum Asia

1 Year $10.99

Save 7%

Buy this issue $0.99

Gift BioSpectrum Asia

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Verified Secure
Payment

In this issue

CELEBRATING WOMANHOOD ON EQUAL NOTE

As nations around the world celebrate International Women’s Day on March 8, with the theme #EachforEqual, the number of companies that have had women in a leadership role continues to expand. But the list is still relatively short, and even when women have made it to power, they have rarely led for a long time. Globally women at leadership position are very less and only 4.9 per cent of Fortune 500 companies have women at leadership position.

Indeed, women are getting stronger and more engaged in careers, with age no bar. Some are taking greater risks, often to make a greater impact. Some have just stepped into the waters, while some have made it big through their hard work and determination. Celebrating the power of womanhood, BioSpectrum has profiled leaders from Asia Pacific, entrepreneurs, and family business heiress in the life sciences industry, who are yet to achieve a milestone of reaching the top position, but are already adding to the company in ways that enrich it.

How Pharma Firms Are Gearing Up To Tackle Coronavirus?

The first confirmed death from COVID-19 occurred on January 9, 2020 and marked the beginning of the race to find treatment that will treat and prevent the ill effects of this Coronavirus. Let’s look at how pharma firms are gearing up to tackle this global endemic.

5 mins

Public Goods for Health is a concept which is very much a focus of WHO

From Director General (DG), Indian Council of Medical research (ICMR) and Secretary, Department of Health Research, Dr Soumya Swaminathan went to Geneva in October 2017 to take over as the Deputy Director General (DDG) of Programmes at the World Health Organisation (WHO), to be the first Indian to hold this position. Exactly a year back, in March 2019, she took over as the WHO’s first Chief Scientist, a new position heading a division created as a part of sweeping reforms at WHO to have an explicit focus on science. A year after taking over the new and important position at an international level that is expected to create a foundation for a new department, Dr. Soumya Swaminathan spoke to Milind Kokje, chief editor, BioSpectrum while she was in Chennai, India recently about her new role, its responsibilities and other health related issues. Edited excerpts;

9 mins

CELEBRATING WOMANHOOD ON EQUAL NOTE

As nations around the world celebrate International Women’s Day on March 8, with the theme #EachforEqual, the number of companies that have had women in a leadership role continues to expand. But the list is still relatively short, and even when women have made it to power, they have rarely led for a long time. Globally women at leadership position are very less and only 4.9 per cent of Fortune 500 companies have women at leadership position.

CELEBRATING WOMANHOOD ON EQUAL NOTE

10+ mins

Exciting time for digital health players

Digital Health has gained much importance, development and investment in the last decade. The year 2019, continued the strong upward trend in health innovation funding. With $13.7 billion in total funding across 727 deals, and was the second most-funded year ever, according to Startup Health. Boasting three out of 2019’s top 10 most-funded cities, China cemented its place as a hub for health innovation, and is positioned for continued growth. The last decade saw the emergence of telemedicine, Big Data, disruption in consumer wellness and healthcare, etc. As the digital health industry matures, there will be new challenges pertaining to data privacy, regulations, digital medicines, etc. Let’s look at the possibilities for digital health in the coming decade.

4 mins

Where AR & VR Are Headed In Life Sciences Industry?

The rise of MedTech is transforming the healthcare industry, as augmented reality (AR) and virtual reality (VR) have pushed the right buttons with players by offering high-tech solutions to fix prevailing challenges in medical training, diagnostics, and treatments. The development of state-of-the-art technologies such as digital reality has disrupted the industrial scenario, and tools such as AR and VR have gained immense popularity in one stroke. Yet, the industrial adoption of digital reality remained significantly low since its inception, and the application range was fairly narrow due to low penetration and high cost of AR and VR tools.

Where AR & VR Are Headed In Life Sciences Industry?

5 mins

We secure approvals – US FDA and CE marking before the end of 2020

Incorporated in early 2018, Pune, India based health tech startup In-Med Prognostics has developed an artificial intelligence (AI) based brain health diagnostic and prognostic tool called NeuroShield, which is one-of-its-kind in India. It is a cloud-based clinical decision support tool for neurological disorders. The tool utilizes three dimensional (3D) based magnetic resonance images to their full potential by extracting data and providing volumetric analysis for the brain and its various structures. The analysis of NeuroShield enables actionable, quantitative, objective decision making to the neuro-physicians for differential diagnosis. To gather more information on this innovative product, BioSpectrum spoke to Dr Latha Poonamallee, Cofounder & Chairperson, In-Med Prognostics, Pune in India. Edited Excerpts;

We secure approvals – US FDA and CE marking before the end of 2020

4 mins

Eppendorf is investing disproportionately in expansion of its global locations, particularly in Asia

Hamburg based Eppendorf AG on December 6, 2019 has appointed Eva van Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Business Area Sample Handling, as Co-Chief Executive Officers of Eppendorf AG. Both will succeed Thomas Bachmann, the former President & CEO of Eppendorf AG, who has already left the company. Eppendorf, founded in Hamburg, Germany in 1945, has more than 3,300 employees worldwide. The company has subsidiaries in 26 countries and is represented in all important markets by distributors. In an interaction with BioSpectrum Eva van Pelt shared her new role and plans for next five years. Edited excerpts;

Eppendorf is investing disproportionately in expansion of its global locations, particularly in Asia

4 mins

CCPA and pharma marketers

The CCPA, what it entails, how pharma marketers might be affected, and what they can do to prepare for the law’s 2020 implementation.

CCPA and pharma marketers

3 mins

Read all stories from BioSpectrum Asia

BioSpectrum Asia Magazine Description:

PublisherMM Activ Sci-Tech Communication

CategoryBusiness

LanguageEnglish

FrequencyMonthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View All